Researchers have identified a newly recognized enzyme called IDOL as a potential key driver of Alzheimer’s disease. In a breakthrough study, scientists found that removing the enzyme from neurons significantly reduced the buildup of amyloid plaques, one of the hallmark features of Alzheimer’s.
The discovery also improved important brain functions related to cell communication, resilience, and neural health. Scientists believe targeting IDOL could open the door to a new generation of Alzheimer’s treatments designed not only to slow disease progression but also to better protect the brain from ongoing damage and cognitive decline.
The findings offer promising new hope in the search for more effective dementia therapies.
Read more at ScienceDaily
